High‐Dimensional Analysis of Type 2 Lymphocyte Dynamics During Mepolizumab or Dupilumab Treatment in Severe Asthma. Allergy, 2025; DOI: 10.1111/all.16633 ...

The Asthma and Allergy Foundation says more than 100 million people in the U.S. have asthma, a chronic inflammatory disease of the airways, and/or allergies, which can trigger asthma symptoms.